This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 Stocks Under $10 Soaring Higher

Keryx Biopharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Keryx Biopharmaceuticals (KERX - Get Report) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease. This stock is trading up 15.8% at $1.68 in recent trading.

Today's Range: $1.64-$1.76

52-Week Range: $1.28-$5.55

Volume: 4 million

Three-Month Average Volume: 3.8 million

Shares of KERX are skyrocketing today after Roth Capital Partners raised the stock to a buy rating from neutral.

From a technical perspective, KERX is gapping up sharply here on above average volume. This move is quickly pushing the stock within range of triggering a near-term breakout trade. That trade will hit once KERX takes out some near-term overhead resistance at $1.75 to $1.97 with high-volume.

Traders should now look for long-biased trades if KERX can sustain a move or close above those levels on volume that's near or above 3,791,530 shares. If we get that action soon, then KERX will a great chance of filling some of its massive gap-down from two months ago.

Keryx was included on a list of 10 Best-Performing Stocks in a Three-Year Bull Market.
2 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BIOS $2.70 -0.37%
CSIQ $18.68 -0.05%
KERX $5.26 0.00%
LYV $21.73 0.00%
RPRX $2.41 -0.41%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs